Cytokinetics says MYQORZO launch momentum is accelerating
TradingView news notes stronger uptake by new prescribers, faster conversion to paid therapy, and planned European expansion with further label extensions and guideline updates supported by clinical data.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.